WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer’s Disease Diagnostic Company Superfluid Dx

More Accurate Test expected to become Indispensable Tool for Clinical Practice PALO ALTO, Calif., Dec. 20, 2023 /PRNewswire/ — WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ…

Click here to view original post